Treatment guidelines for lead exposure in children. American Academy of Pediatrics Committee on Drugs.
D002614:Chelating Agents / Q000627:therapeutic use*; D002648:Child; D004112:Dimercaprol / Q000627:therapeutic use; D004492:Edetic Acid / Q000627:therapeutic use; D006801:Humans; D007855:Lead Poisoning / Q000188:drug therapy*; D010396:Penicillamine / Q000627:therapeutic use; D004113:Succimer / Q000627:therapeutic use
D002614:Chelating Agents; D004112:Dimercaprol; D004492:Edetic Acid; D004113:Succimer; D010396:Penicillamine